Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 08 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-19.57 Insider Own1.97% Shs Outstand25.10M Perf Week-5.94%
Market Cap5.17M Forward P/E- EPS next Y-0.63 Insider Trans59.76% Shs Float24.60M Perf Month-46.35%
Income-19.59M PEG- EPS next Q-0.27 Inst Own2.23% Short Float / Ratio1.96% / 0.07 Perf Quarter-77.17%
Sales0.00M P/S- EPS this Y79.37% Inst Trans-0.54% Short Interest0.48M Perf Half Y-92.59%
Book/sh0.42 P/B0.50 EPS next Y88.69% ROA-176.17% Target Price3.00 Perf Year-98.95%
Cash/sh0.30 P/C0.69 EPS next 5Y- ROE-308.93% 52W Range0.15 - 21.40 Perf YTD-98.47%
Dividend- P/FCF- EPS past 5Y- ROI-423.20% 52W High-99.04% Beta-0.31
Dividend %- Quick Ratio1.67 Sales past 5Y0.00% Gross Margin- 52W Low37.88% ATR0.05
Employees19 Current Ratio1.67 Sales Q/Q- Oper. Margin0.00% RSI (14)35.48 Volatility8.12% 17.53%
OptionableNo Debt/Eq0.13 EPS Q/Q74.61% Profit Margin- Rel Volume0.14 Prev Close0.20
ShortableYes LT Debt/Eq0.04 EarningsNov 15 BMO Payout- Avg Volume7.08M Price0.21
Recom1.00 SMA20-20.24% SMA50-41.66% SMA200-93.77% Volume1,000,317 Change2.49%
Dec-05-23 09:00AM
Dec-04-23 04:10PM
Nov-30-23 02:53PM
Nov-14-23 04:30PM
Oct-30-23 04:33PM
08:16AM Loading…
Oct-27-23 08:16AM
Oct-26-23 04:19PM
Oct-24-23 08:00AM
Oct-16-23 08:00AM
Sep-28-23 04:02PM
Sep-25-23 08:01PM
Aug-23-23 08:00AM
04:45PM Loading…
Aug-14-23 04:45PM
Jul-31-23 07:00AM
Jul-13-23 12:43PM
Jul-10-23 09:55AM
Jul-05-23 07:00AM
Jun-28-23 03:49PM
Jun-23-23 09:24AM
Jun-22-23 07:00AM
Jun-09-23 04:05PM
Jun-07-23 11:00AM
Jun-06-23 05:29PM
May-22-23 07:00AM
Apr-27-23 07:00AM
Apr-26-23 08:00AM
07:00AM Loading…
Apr-14-23 07:00AM
Apr-06-23 07:00AM
Apr-05-23 07:00AM
Apr-04-23 09:00PM
Apr-03-23 08:00AM
Mar-31-23 04:01PM
Feb-28-23 07:00AM
Feb-22-23 08:00AM
Feb-18-23 08:42AM
Feb-17-23 04:10PM
Feb-16-23 08:00AM
Feb-01-23 07:49AM
Jan-31-23 04:05PM
Dec-29-22 09:34AM
Dec-07-22 02:37PM
Dec-06-22 04:20PM
Nov-30-22 07:00AM
Nov-14-22 04:15PM
Nov-09-22 07:00AM
Nov-08-22 03:40PM
Nov-07-22 08:00AM
Oct-26-22 10:51AM
Oct-19-22 08:00AM
Oct-13-22 07:00AM
Sep-27-22 08:00AM
Sep-08-22 08:00AM
Aug-15-22 04:15PM
Aug-02-22 07:00AM
Jul-11-22 04:05PM
Jul-04-22 03:13PM
Jun-09-22 09:00AM
Jun-01-22 09:00AM
May-20-22 09:00AM
May-19-22 09:00AM
May-16-22 08:30AM
Apr-13-22 09:00AM
Apr-05-22 07:17AM
Mar-31-22 04:30PM
Mar-25-22 12:00PM
Mar-23-22 09:00AM
Feb-14-22 09:00AM
Feb-10-22 09:46AM
Jan-06-22 03:17PM
Dec-06-21 07:10PM
Nov-18-21 10:57AM
Nov-15-21 04:01PM
Nov-09-21 07:30AM
Sep-30-21 04:01PM
Sep-23-21 11:05AM
Aug-23-21 04:01PM
Aug-05-21 07:30AM
Jul-13-21 04:30PM
Jul-09-21 04:48PM
Jul-08-21 06:34PM
TransCode Therapeutics, Inc. engages in the development and commercializing of diagnostics and therapeutics for the detection and treatment of cancer. The company was founded by Robert Michael Dudley, Zdravka Medarova, and Anna Moore in January 2016 and is headquartered in Boston, MA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dudley Robert MichaelChief Executive OfficerSep 28Buy0.5198,00049,980180,262Oct 02 04:37 PM
Fitzgerald Thomas AChief Financial OfficerSep 28Buy0.5149,35025,16856,318Oct 02 04:39 PM
Dudley Robert MichaelChief Executive OfficerJun 21Buy2.6512,00031,81882,262Jun 22 06:23 PM
Dudley Robert MichaelChief Executive OfficerJun 20Buy2.556,60716,84770,262Jun 22 06:23 PM
Dudley Robert MichaelChief Executive OfficerJun 09Buy2.7619,00052,440912,114Jun 13 04:16 PM